- Home
- SKYH vs GOSS Comparison
SKYH vs GOSS Comparison
Compare SKYH & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- GOSS
- Stock Information
- Founded
- SKYH 2017
- GOSS 2015
- Country
- SKYH United States
- GOSS United States
- Employees
- SKYH N/A
- GOSS N/A
- Industry
- SKYH Military/Government/Technical
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- GOSS Health Care
- Exchange
- SKYH Nasdaq
- GOSS Nasdaq
- Market Cap
- SKYH 280.3M
- GOSS 214.7M
- IPO Year
- SKYH N/A
- GOSS 2019
- Fundamental
- Price
- SKYH $10.97
- GOSS $0.96
- Analyst Decision
- SKYH Strong Buy
- GOSS Strong Buy
- Analyst Count
- SKYH 3
- GOSS 5
- Target Price
- SKYH $14.00
- GOSS $9.20
- AVG Volume (30 Days)
- SKYH 78.7K
- GOSS 910.5K
- Earning Date
- SKYH 11-07-2024
- GOSS 11-07-2024
- Dividend Yield
- SKYH N/A
- GOSS N/A
- EPS Growth
- SKYH N/A
- GOSS N/A
- EPS
- SKYH N/A
- GOSS N/A
- Revenue
- SKYH $10,762,000.00
- GOSS $95,842,000.00
- Revenue This Year
- SKYH $89.29
- GOSS N/A
- Revenue Next Year
- SKYH $107.71
- GOSS N/A
- P/E Ratio
- SKYH N/A
- GOSS N/A
- Revenue Growth
- SKYH 177.73
- GOSS N/A
- 52 Week Low
- SKYH $5.24
- GOSS $0.45
- 52 Week High
- SKYH $13.60
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- SKYH 44.80
- GOSS 48.30
- Support Level
- SKYH $10.58
- GOSS $0.93
- Resistance Level
- SKYH $11.58
- GOSS $1.09
- Average True Range (ATR)
- SKYH 0.44
- GOSS 0.05
- MACD
- SKYH -0.07
- GOSS -0.01
- Stochastic Oscillator
- SKYH 39.20
- GOSS 20.31
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.